Natural History Study of HIV Acquired in Infancy or Childhood
NCT00924365 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 54
Last updated 2019-12-17
Summary
Background:
* About 10,000 children in the United States have been living with HIV infection since birth. Little is known about the long-term effects of HIV infection and its treatment on the growth and development of these children.
* Because of their disease, many children with HIV face additional difficulties with their health, well-being and development, such as success in school and peer relationships.
Objectives:
* To better understand how HIV infection and the medicines used to treat it affect the growth and development of children, adolescents and young adults who have been infected since birth or when they were very young.
* To develop ways to improve the quality of life for these individuals.
Eligibility:
-HIV-infected patients who were followed by the pediatric HIV program in NCI as of December 2004, or an HIV-infected sibling of a participant.
Design:
* Periodic evaluation of pubertal development; bone mineralization; body composition and fat distribution; liver, kidney and heart status; and behavioral, cognitive and academic or vocational outcome of the study group. Evaluations include the following:
* Physical examinations, including height and weight measurements and skin-fold thickness testing to measure body fat.
* Review of medical records and family history.
* Blood and urine tests, including pregnancy test in females who can bear children.
* DEXA scans (X-ray test to measure bone strength and how much fat, muscle and bone is in the body).
* Neuropsychological testing, including evaluation of language, thinking and problem-solving abilities.
* Magnetic resonance imaging (MRI): Test using a magnetic field and radio waves to examine brain structure and function.
* Oral glucose tolerance test: Blood sampling before and one time after the subject drinks a sugary solution to measure the body's ability to use sugar
Conditions
- HIV Infections
Sponsors & Collaborators
-
National Cancer Institute (NCI)
lead NIH
Principal Investigators
-
Rohan Hazra, M.D. · National Cancer Institute (NCI)
Eligibility
- Min Age
- 6 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2007-02-01
- Completion
- 2014-04-22
Countries
- United States
Study Locations
More Related Trials
-
A Study on the Effect of High-Calorie Infant Formula on Growth and Nutrition in HIV-Infected Infants
NCT00000873 ·Status: COMPLETED ·Phase: NA
-
Psychiatric Problems in Children and Adolescents Infected With HIV at Birth
NCT00100542 ·Status: COMPLETED
-
Long-term Effects of Highly Active Anti-Retroviral Therapy on HIV-Infected Children
NCT00260806 ·Status: COMPLETED
-
Prenatal and Postnatal Studies of Interventions for Prevention of Mother-To-Child Transmission
NCT00028145 ·Status: COMPLETED
-
Anti-HIV Drug Regimens and Treatment-Switching Guidelines in HIV Infected Children
NCT00039741 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Prevalence of Hepatitis C Virus Infection in HIV-Infected Children
NCT00037076 ·Status: COMPLETED
-
A Study of Ritonavir (an Anti-HIV Drug) in HIV-Positive Infants and Children
NCT00000952 ·Status: COMPLETED ·Phase: PHASE1
-
Correlation of HIV Levels With Clinical and Immunologic Outcome in Children Treated With Didanosine
NCT00026676 ·Status: COMPLETED
-
Cohort of HIV-infected Children
NCT03235258 ·Status: COMPLETED
-
Immune Function of Infants With HIV
NCT00073229 ·Status: COMPLETED
-
Vitamin D Supplementation and CD4 Count in HIV-Infected Children
NCT00911664 ·Status: COMPLETED ·Phase: PHASE2
-
When to Start Anti-HIV Drugs in Children Infected With HIV (The PREDICT Study)
NCT00234091 ·Status: COMPLETED ·Phase: PHASE3
-
A Multicenter Trial To Evaluate Oral Retrovir in the Treatment of Children With Symptomatic HIV Infection
NCT00000716 ·Status: COMPLETED ·Phase: PHASE2
-
Becoming HIV-Exposed, Uninfected Children Born to HIV-Positive Mothers Followed at Bichat Claude Bernard Hospital
NCT06666543 ·Status: COMPLETED
-
Safety and Immunogenicity Study of Candidate HIV-1 Vaccine Given to Healthy Infants Born to HIV-1-infected Mothers
NCT00981695 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Therapeutic Drug Monitoring and Viral Resistance Testing in the Treatment of HIV-Infected Children
NCT00032669 ·Status: COMPLETED ·Phase: PHASE1
-
Pneumococcal Vaccine and Routine Pediatric Immunizations in HIV-Infected Children Receiving Anti-HIV Drugs
NCT00013871 ·Status: COMPLETED ·Phase: NA
-
A Study of 1592U89 in HIV-Infected Children
NCT00002197 ·Status: COMPLETED ·Phase: NA
-
A Phase III Study to Evaluate the Safety, Tolerance, and Efficacy of Early Treatment With Zidovudine (AZT) in Asymptomatic Infants With HIV Infection
NCT00000750 ·Status: COMPLETED ·Phase: PHASE3
-
Prevalence of Proteinuria and Chronic Kidney Disease in Pediatric HIV-Infected Patients
NCT00153621 ·Status: COMPLETED
-
Very Early Intensive Treatment of Infants Living With HIV to Achieve HIV Remission
NCT02140255 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Nutritional and Metabolic Disorders in HIV Infected Children and Adolescent
NCT01771562 ·Status: COMPLETED
-
A Blood Test to Look at Cells of the Immune System in Healthy Children
NCT00001109 ·Status: COMPLETED
-
Interventions to Decrease the Risk of Mother-to-Child Transmission of HIV in India
NCT00341796 ·Status: COMPLETED
-
Anti-HIV Drugs for Treating Infants Who Acquired HIV Infection at Birth
NCT00102960 ·Status: COMPLETED ·Phase: PHASE3